Come up with a name for your new list and we'll add to it:
Rapamycin Holdings raised a round of funding on February 03, 2014. Investors include
UT Horizon Fund.
Rapamycin Holdings licenses rapamycin-related intellectual property developed at the UTHSCSA. Rapamycin, a drug federally approved to suppress organ rejection, continues to be studied for its potentia…